Multiple sclerosis (MS) is a chronic, inflammatory, demyelinating disease of the central nervous system (CNS). White matter lesions in MS are surrounded by areas of non-demyelinated normal appearing white matter (NAWM) with complex pathology, including blood brain barrier dysfunction, axonal damage and glial activation. Astrocytes, the most abundant cell type within the CNS, may respond and/or contribute to lesion pathogenesis. We aimed to characterise the transcriptomic profile of astrocytes in NAWM to determine whether specific glial changes exist in the NAWM which contribute to lesion development or prevent disease progression. Astrocytes were isolated from control and NAWM by laser capture microdissection (LCM), using glial fibrillary acidic protein (GFAP) as a marker, and the astrocyte transcriptome determined using microarray analysis. 452 genes were significantly differentially expressed (208 up-regulated and 244 down-regulated, FC ≥ 1.5 and pvalue ≤ 0.05). Within the NAWM, astrocytes were associated with significant upregulation of genes involved in the control of iron homeostasis (including metallothionein-1 and -2, ferritin light chain and transferrin), oxidative stress responses, the immune response and neurotrophic support. These findings suggest a neuroprotective role of astrocytes in the NAWM in MS.
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Introduction
Multiple sclerosis (MS) is a complex disease neuropathologically characterised by demyelinated lesions distributed throughout the brain and spinal cord, inflammation, axonal/neuronal damage, gliosis, oxidative stress, excitotoxicity and blood brain barrier (BBB) dysfunction (Stables et al., 2010) . Subtle pathological changes exist in the normal appearing white matter (NAWM) that are not detected by standard magnetic resonance imaging (MRI) and are only identifiable upon immunohistochemical evaluation, including mild inflammation, microglial activation, astrogliosis, axonal swelling, cellular infiltration and reduced myelin density (Moll et al., 2011; Allen et al., 2001; Allen and McKeown, 1979; Kutzelnigg et al., 2005; Lund et al., 2013) . The cause of these changes in the white matter in MS are unknown but may be a result of underlying molecular pathology, or they may represent lesions that are beyond the sensitivity of current imaging techniques (Mistry et al., 2011) . In order to better understand the pathogenesis of the disease and the mechanisms underlying lesion development, the processes that occur within the surrounding NAWM need to be identified.
Astrocytes play a key role in maintaining the extracellular environment and supporting neurons (Sobel & Moore 2008) . While it has been suggested that astrocytes play a neuroprotective role in MS by inhibiting demyelination (Miljkovic et al., 2011) , releasing anti-inflammatory cytokines (Bsibsi et al., 2006) and secreting proteins involved in myelin repair and neurotrophins to support regeneration of neurons (Marz et al., 1999; Moore et al., 2011a; Moore et al., 2011b; Mason et al., 2001; Miljkovic et al., 2011) , it has also been proposed that astrocytes are detrimental in disease pathogenesis by releasing pro-inflammatory cytokines, contributing to BBB dysfunction (Argaw et al., 2006; Argaw et al., 2012) and preventing oligodendrocyte precursor cell (OPC) maturation into remyelinating oligodendrocytes (Messersmith et al., 2000; Sarchielli et al., 2008) .
The advancement of transcriptomic technology enables studies to be carried out to identify the genetic profile associated with the pathogenesis of disease. To date, gene expression profiling in MS has focussed on the differences between demyelinated lesions and neurological control WM, as reviewed (Dutta and Trapp, 2012; Dutta, 2013) . MS is a heterogeneous and progressive disease where the architecture of the brain tissue is constantly changing depending on the stage of the disease (Bradl and Lassmann, 2012) . Consequently, investigating NAWM as opposed
